Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Colonic Neoplasms × toripalimab × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Solid Tumor 9 Solid Tumor 5 Uterine Cervical Neoplasms 4 Nasopharyngeal Carcinoma 4 Carcinoma, Non-Small-Cell Lung 4 Triple Negative Breast Neoplasms 3 Melanoma 3 Carcinoma, Hepatocellular 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Locally Advanced or Metastatic Solid Tumors 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Advanced Solid Tumors 2 Advanced Lung Cancer 2 Stomach Neoplasms 1 Solid Tumor, Adult 1 Solid Cancer 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 PD-1 1 Ovarian Neoplasms 1 Meningeal Carcinomatosis 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Liposarcoma 1 Head and Neck Squamous Cell Cancer 1

Interventions

Oxaliplatin 15 Irinotecan 11 Fluorouracil 11 Leucovorin 9 Bevacizumab 8 pembrolizumab 7 Cetuximab 7 Capecitabine 6 Cyclophosphamide 5 fludarabine 4 aldesleukin 4 Panitumumab 4 Nivolumab 4 Folfox protocol 4 oblimersen 3 selpercatinib 2 poly ICLC 2 labetuzumab 2 dehydroftorafur 2 conatumumab 2 bintrafusp alfa protein, human 2 Receptor Protein-Tyrosine Kinases 2 Levoleucovorin 2 Interleukin-2 2 Gemcitabine 2 Gefitinib 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Chemotherapy, Adjuvant 2 BCG Vaccine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03985891 2020-12-17

JSFOL

Xiangya Hospital of Central South University

Phase 1/2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡